- Home
- PDFS vs TSHA Comparison
PDFS vs TSHA Comparison
Compare PDFS & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDFS
- TSHA
- Stock Information
- Founded
- PDFS 1992
- TSHA 2019
- Country
- PDFS United States
- TSHA United States
- Employees
- PDFS N/A
- TSHA N/A
- Industry
- PDFS EDP Services
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- PDFS Technology
- TSHA Health Care
- Exchange
- PDFS Nasdaq
- TSHA Nasdaq
- Market Cap
- PDFS 764.2M
- TSHA 728.4M
- IPO Year
- PDFS N/A
- TSHA 2020
- Fundamental
- Price
- PDFS $20.28
- TSHA $3.00
- Analyst Decision
- PDFS Strong Buy
- TSHA Strong Buy
- Analyst Count
- PDFS 3
- TSHA 7
- Target Price
- PDFS $33.33
- TSHA $8.71
- AVG Volume (30 Days)
- PDFS 303.3K
- TSHA 2.6M
- Earning Date
- PDFS 08-07-2025
- TSHA 08-12-2025
- Dividend Yield
- PDFS N/A
- TSHA N/A
- EPS Growth
- PDFS N/A
- TSHA N/A
- EPS
- PDFS 0.02
- TSHA N/A
- Revenue
- PDFS $196,000,000.00
- TSHA $8,098,000.00
- Revenue This Year
- PDFS $23.39
- TSHA N/A
- Revenue Next Year
- PDFS $18.37
- TSHA N/A
- P/E Ratio
- PDFS $935.14
- TSHA N/A
- Revenue Growth
- PDFS 17.76
- TSHA N/A
- 52 Week Low
- PDFS $15.91
- TSHA $1.05
- 52 Week High
- PDFS $33.42
- TSHA $3.31
- Technical
- Relative Strength Index (RSI)
- PDFS 45.32
- TSHA 63.38
- Support Level
- PDFS $19.00
- TSHA $2.76
- Resistance Level
- PDFS $19.91
- TSHA $3.05
- Average True Range (ATR)
- PDFS 1.06
- TSHA 0.15
- MACD
- PDFS -0.14
- TSHA 0.00
- Stochastic Oscillator
- PDFS 44.08
- TSHA 75.51
About PDFS PDF Solutions Inc.
PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.